| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 7.82e-10 | 303 | 32 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | SMARCC1 BCL9L ARID1B TCERG1 SS18 TOX2 CREBBP SF1 EP300 ZMIZ2 | 1.06e-08 | 562 | 32 | 10 | GO:0003712 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.37e-07 | 167 | 32 | 6 | GO:0031490 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SMARCC1 BCL9L ARID1B TCERG1 SS18 TOX2 RBM33 CREBBP SF1 EP300 ZMIZ2 | 1.01e-06 | 1160 | 32 | 11 | GO:0030674 |
| GeneOntologyMolecularFunction | chromatin binding | 1.62e-06 | 739 | 32 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 2.49e-06 | 2 | 32 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 2.49e-06 | 2 | 32 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SMARCC1 BCL9L ARID1B TCERG1 SS18 TOX2 RBM33 CREBBP SF1 EP300 ZMIZ2 | 4.64e-06 | 1356 | 32 | 11 | GO:0060090 |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 7.46e-06 | 3 | 32 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 1.36e-04 | 11 | 32 | 2 | GO:0004143 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.58e-04 | 15 | 32 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | SMAD binding | 3.50e-04 | 86 | 32 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 5.13e-04 | 21 | 32 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.10e-03 | 753 | 32 | 6 | GO:0008134 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.44e-03 | 140 | 32 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.60e-03 | 37 | 32 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.60e-03 | 37 | 32 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.72e-03 | 1459 | 32 | 8 | GO:0000977 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 1.96e-03 | 41 | 32 | 2 | GO:0001727 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.02e-03 | 51 | 32 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 3.38e-03 | 54 | 32 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 3.50e-03 | 55 | 32 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 4.16e-03 | 60 | 32 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.24e-03 | 417 | 32 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 4.29e-03 | 61 | 32 | 2 | GO:0030374 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 5.78e-03 | 229 | 32 | 3 | GO:0003714 | |
| GeneOntologyMolecularFunction | p53 binding | 6.75e-03 | 77 | 32 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 6.93e-03 | 78 | 32 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 7.81e-03 | 83 | 32 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 7.99e-03 | 84 | 32 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | histone binding | 8.63e-03 | 265 | 32 | 3 | GO:0042393 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.07e-02 | 98 | 32 | 2 | GO:0031491 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.16e-02 | 102 | 32 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.20e-02 | 104 | 32 | 2 | GO:0016407 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.29e-02 | 891 | 32 | 5 | GO:0008270 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.34e-02 | 582 | 32 | 4 | GO:0140297 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.43e-02 | 320 | 32 | 3 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.51e-02 | 326 | 32 | 3 | GO:0001217 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.58e-02 | 120 | 32 | 2 | GO:0008013 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.76e-02 | 127 | 32 | 2 | GO:0008094 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SMARCC1 ETV5 BCL9L CHD7 PAX6 ATRX TCERG1 NFAT5 SS18 TOX2 CREBBP EP300 ZMIZ2 | 3.67e-08 | 1390 | 31 | 13 | GO:0045944 |
| GeneOntologyBiologicalProcess | chromatin remodeling | 9.41e-07 | 741 | 31 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | chromatin organization | 4.50e-06 | 896 | 31 | 9 | GO:0006325 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 1.09e-05 | 999 | 31 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.31e-05 | 4 | 31 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | face development | 1.15e-04 | 63 | 31 | 3 | GO:0060324 | |
| GeneOntologyBiologicalProcess | lipid phosphorylation | 1.19e-04 | 11 | 31 | 2 | GO:0046834 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 1.24e-04 | 1053 | 31 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 1.52e-04 | 1399 | 31 | 9 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 1.64e-04 | 1413 | 31 | 9 | GO:1902679 | |
| GeneOntologyBiologicalProcess | regulation of nuclear cell cycle DNA replication | 2.27e-04 | 15 | 31 | 2 | GO:0033262 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 2.59e-04 | 16 | 31 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 2.59e-04 | 16 | 31 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 2.81e-04 | 1186 | 31 | 8 | GO:0007167 | |
| GeneOntologyBiologicalProcess | positive regulation of cell fate commitment | 3.29e-04 | 18 | 31 | 2 | GO:0010455 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | 3.69e-04 | 1235 | 31 | 8 | GO:0003006 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 3.87e-04 | 95 | 31 | 3 | GO:2000781 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 4.19e-04 | 237 | 31 | 4 | GO:0019827 | |
| GeneOntologyBiologicalProcess | DNA damage response | 4.53e-04 | 959 | 31 | 7 | GO:0006974 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 4.53e-04 | 242 | 31 | 4 | GO:0098727 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 4.89e-04 | 445 | 31 | 5 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 4.91e-04 | 103 | 31 | 3 | GO:2000628 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 5.42e-04 | 23 | 31 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 5.42e-04 | 23 | 31 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 5.42e-04 | 23 | 31 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.77e-04 | 115 | 31 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 7.02e-04 | 482 | 31 | 5 | GO:0007178 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 7.43e-04 | 276 | 31 | 4 | GO:0007179 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 7.48e-04 | 119 | 31 | 3 | GO:0010586 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 8.06e-04 | 28 | 31 | 2 | GO:0018394 | |
| GeneOntologyBiologicalProcess | diacylglycerol metabolic process | 8.06e-04 | 28 | 31 | 2 | GO:0046339 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 8.65e-04 | 29 | 31 | 2 | GO:2000819 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 8.65e-04 | 29 | 31 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 1.03e-03 | 525 | 31 | 5 | GO:0009410 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 1.10e-03 | 136 | 31 | 3 | GO:0045445 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 1.19e-03 | 34 | 31 | 2 | GO:0008356 | |
| GeneOntologyBiologicalProcess | negative regulation of miRNA metabolic process | 1.19e-03 | 34 | 31 | 2 | GO:2000629 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 1.24e-03 | 317 | 31 | 4 | GO:1903039 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 1.26e-03 | 35 | 31 | 2 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 1.26e-03 | 35 | 31 | 2 | GO:0030511 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 1.27e-03 | 143 | 31 | 3 | GO:0045739 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.30e-03 | 144 | 31 | 3 | GO:0045582 | |
| GeneOntologyBiologicalProcess | phosphatidic acid biosynthetic process | 1.33e-03 | 36 | 31 | 2 | GO:0006654 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 1.35e-03 | 146 | 31 | 3 | GO:2000779 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 1.42e-03 | 564 | 31 | 5 | GO:0051052 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 1.46e-03 | 850 | 31 | 6 | GO:0071363 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 1.49e-03 | 333 | 31 | 4 | GO:0051054 | |
| GeneOntologyBiologicalProcess | muscle structure development | 1.54e-03 | 858 | 31 | 6 | GO:0061061 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.54e-03 | 336 | 31 | 4 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.66e-03 | 343 | 31 | 4 | GO:0071559 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 1.73e-03 | 41 | 31 | 2 | GO:0060325 | |
| GeneOntologyBiologicalProcess | positive regulation of collagen biosynthetic process | 1.73e-03 | 41 | 31 | 2 | GO:0032967 | |
| GeneOntologyBiologicalProcess | phosphatidic acid metabolic process | 1.73e-03 | 41 | 31 | 2 | GO:0046473 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.73e-03 | 347 | 31 | 4 | GO:0090092 | |
| GeneOntologyBiologicalProcess | response to growth factor | 1.78e-03 | 883 | 31 | 6 | GO:0070848 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 1.81e-03 | 42 | 31 | 2 | GO:0070316 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine modification | 1.82e-03 | 162 | 31 | 3 | GO:0018205 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 1.82e-03 | 162 | 31 | 3 | GO:0045621 | |
| GeneOntologyBiologicalProcess | sex differentiation | 1.82e-03 | 352 | 31 | 4 | GO:0007548 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 1.83e-03 | 598 | 31 | 5 | GO:0080135 | |
| GeneOntologyBiologicalProcess | behavior | 1.86e-03 | 891 | 31 | 6 | GO:0007610 | |
| GeneOntologyBiologicalProcess | positive regulation of collagen metabolic process | 1.99e-03 | 44 | 31 | 2 | GO:0010714 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 1.99e-03 | 44 | 31 | 2 | GO:0045023 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 2.06e-03 | 614 | 31 | 5 | GO:0010720 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 2.15e-03 | 917 | 31 | 6 | GO:0016071 | |
| GeneOntologyBiologicalProcess | nuclear DNA replication | 2.17e-03 | 46 | 31 | 2 | GO:0033260 | |
| GeneOntologyBiologicalProcess | head development | 2.18e-03 | 919 | 31 | 6 | GO:0060322 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 2.36e-03 | 48 | 31 | 2 | GO:0060323 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 2.45e-03 | 382 | 31 | 4 | GO:0030217 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 2.48e-03 | 383 | 31 | 4 | GO:0048608 | |
| GeneOntologyBiologicalProcess | reproductive system development | 2.60e-03 | 388 | 31 | 4 | GO:0061458 | |
| GeneOntologyBiologicalProcess | DNA repair | 2.60e-03 | 648 | 31 | 5 | GO:0006281 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 2.62e-03 | 389 | 31 | 4 | GO:0022409 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 2.65e-03 | 185 | 31 | 3 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 2.65e-03 | 185 | 31 | 3 | GO:0035108 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 2.66e-03 | 51 | 31 | 2 | GO:1902459 | |
| GeneOntologyBiologicalProcess | cell cycle DNA replication | 2.66e-03 | 51 | 31 | 2 | GO:0044786 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated DNA replication | 2.87e-03 | 53 | 31 | 2 | GO:0090329 | |
| GeneOntologyBiologicalProcess | olfactory bulb development | 2.87e-03 | 53 | 31 | 2 | GO:0021772 | |
| GeneOntologyBiologicalProcess | regulation of cell fate commitment | 2.87e-03 | 53 | 31 | 2 | GO:0010453 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 2.95e-03 | 192 | 31 | 3 | GO:0017015 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 2.98e-03 | 54 | 31 | 2 | GO:0045663 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 3.08e-03 | 195 | 31 | 3 | GO:1903844 | |
| GeneOntologyBiologicalProcess | protein destabilization | 3.20e-03 | 56 | 31 | 2 | GO:0031648 | |
| GeneOntologyCellularComponent | npBAF complex | 1.17e-06 | 14 | 32 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | chromatin | SMARCC1 ETV5 ARID1B CHD7 PAX6 ATRX NFAT5 SS18 CREBBP EP300 ZMIZ2 | 6.94e-06 | 1480 | 32 | 11 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.29e-05 | 30 | 32 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | GBAF complex | 2.04e-04 | 14 | 32 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | brahma complex | 2.04e-04 | 14 | 32 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | transcription regulator complex | 2.52e-04 | 596 | 32 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | nBAF complex | 2.69e-04 | 16 | 32 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 4.23e-04 | 96 | 32 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 8.79e-04 | 1377 | 32 | 8 | GO:0140513 | |
| GeneOntologyCellularComponent | ATPase complex | 9.99e-04 | 129 | 32 | 3 | GO:1904949 | |
| GeneOntologyCellularComponent | nuclear body | 2.21e-03 | 903 | 32 | 6 | GO:0016604 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 3.16e-03 | 193 | 32 | 3 | GO:0000779 | |
| HumanPheno | Dislocated radial head | 3.52e-06 | 54 | 11 | 4 | HP:0003083 | |
| HumanPheno | Square face | 4.13e-06 | 16 | 11 | 3 | HP:0000321 | |
| HumanPheno | Plantar crease between first and second toes | 4.24e-06 | 2 | 11 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 4.24e-06 | 2 | 11 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 4.24e-06 | 2 | 11 | 2 | HP:0001042 | |
| HumanPheno | Abnormality of the radial head | 4.39e-06 | 57 | 11 | 4 | HP:0003995 | |
| HumanPheno | Abnormality of the humeroradial joint | 6.16e-06 | 62 | 11 | 4 | HP:0100744 | |
| HumanPheno | Abnormal scrotum morphology | 6.56e-06 | 143 | 11 | 5 | HP:0000045 | |
| HumanPheno | Localized hirsutism | 9.76e-06 | 21 | 11 | 3 | HP:0009889 | |
| HumanPheno | Compulsive behaviors | 1.07e-05 | 158 | 11 | 5 | HP:0000722 | |
| HumanPheno | Laryngeal cartilage malformation | 1.27e-05 | 3 | 11 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.27e-05 | 3 | 11 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.27e-05 | 3 | 11 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.27e-05 | 3 | 11 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.27e-05 | 3 | 11 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.27e-05 | 3 | 11 | 2 | HP:0005895 | |
| HumanPheno | Shawl scrotum | 1.68e-05 | 25 | 11 | 3 | HP:0000049 | |
| HumanPheno | Perimembranous ventricular septal defect | 1.90e-05 | 26 | 11 | 3 | HP:0011682 | |
| HumanPheno | Elbow dislocation | 2.08e-05 | 84 | 11 | 4 | HP:0003042 | |
| HumanPheno | Trichiasis | 2.54e-05 | 4 | 11 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 2.54e-05 | 4 | 11 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 2.54e-05 | 4 | 11 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 2.54e-05 | 4 | 11 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 2.54e-05 | 4 | 11 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 2.54e-05 | 4 | 11 | 2 | HP:0031207 | |
| HumanPheno | Upper extremity joint dislocation | 3.53e-05 | 96 | 11 | 4 | HP:0030310 | |
| HumanPheno | Frontal upsweep of hair | 3.95e-05 | 33 | 11 | 3 | HP:0002236 | |
| HumanPheno | Abnormal branching pattern of the aortic arch | 3.95e-05 | 33 | 11 | 3 | HP:0011587 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 4.22e-05 | 5 | 11 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 4.22e-05 | 5 | 11 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 4.22e-05 | 5 | 11 | 2 | HP:0030421 | |
| HumanPheno | Self-injurious behavior | 4.28e-05 | 210 | 11 | 5 | HP:0100716 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 4.62e-05 | 368 | 11 | 6 | HP:0031432 | |
| HumanPheno | Sporadic | 4.67e-05 | 103 | 11 | 4 | HP:0003745 | |
| HumanPheno | Perseverative thought | 5.30e-05 | 377 | 11 | 6 | HP:0030223 | |
| HumanPheno | Vesicoureteral reflux | 5.48e-05 | 221 | 11 | 5 | HP:0000076 | |
| HumanPheno | Abnormality of the ureter | 5.80e-05 | 383 | 11 | 6 | HP:0000069 | |
| HumanPheno | Disordered formal thought process | 6.07e-05 | 386 | 11 | 6 | HP:0025769 | |
| HumanPheno | Large foramen magnum | 6.33e-05 | 6 | 11 | 2 | HP:0002700 | |
| HumanPheno | Abnormal forearm bone morphology | 7.52e-05 | 236 | 11 | 5 | HP:0040072 | |
| HumanPheno | Abnormal thought pattern | 7.86e-05 | 404 | 11 | 6 | HP:5200269 | |
| HumanPheno | Abnormal forearm morphology | 7.99e-05 | 239 | 11 | 5 | HP:0002973 | |
| HumanPheno | Abnormal hair whorl | 8.22e-05 | 42 | 11 | 3 | HP:0010721 | |
| HumanPheno | Deviated nasal septum | 8.85e-05 | 7 | 11 | 2 | HP:0004411 | |
| HumanPheno | Abnormal ureter physiology | 8.99e-05 | 245 | 11 | 5 | HP:0025634 | |
| HumanPheno | Obesity | 1.05e-04 | 425 | 11 | 6 | HP:0001513 | |
| HumanPheno | Prominent fingertip pads | 1.08e-04 | 46 | 11 | 3 | HP:0001212 | |
| HumanPheno | Abnormality of the uterus | 1.11e-04 | 256 | 11 | 5 | HP:0000130 | |
| HumanPheno | Postnatal growth retardation | 1.15e-04 | 258 | 11 | 5 | HP:0008897 | |
| HumanPheno | Prominent digit pad | 1.23e-04 | 48 | 11 | 3 | HP:0011298 | |
| HumanPheno | Abnormal morphology of female internal genitalia | 1.28e-04 | 665 | 11 | 7 | HP:0000008 | |
| HumanPheno | Autism | 1.29e-04 | 264 | 11 | 5 | HP:0000717 | |
| HumanPheno | Hydronephrosis | 1.29e-04 | 264 | 11 | 5 | HP:0000126 | |
| HumanPheno | Radial deviation of finger | 1.41e-04 | 448 | 11 | 6 | HP:0009466 | |
| HumanPheno | Self-mutilation | 1.47e-04 | 51 | 11 | 3 | HP:0000742 | |
| HumanPheno | Pilomatrixoma | 1.51e-04 | 9 | 11 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 1.51e-04 | 9 | 11 | 2 | HP:0002341 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 1.56e-04 | 456 | 11 | 6 | HP:0009485 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 1.65e-04 | 53 | 11 | 3 | HP:0009906 | |
| HumanPheno | Narrow nasal bridge | 1.65e-04 | 53 | 11 | 3 | HP:0000446 | |
| HumanPheno | Panic attack | 1.85e-04 | 55 | 11 | 3 | HP:0025269 | |
| HumanPheno | Frontal hirsutism | 1.89e-04 | 10 | 11 | 2 | HP:0011335 | |
| HumanPheno | Abnormality of refraction | 1.95e-04 | 709 | 11 | 7 | HP:0000539 | |
| HumanPheno | Non-epileptic seizure | 1.95e-04 | 56 | 11 | 3 | HP:0033052 | |
| HumanPheno | Abnormal penis morphology | 2.00e-04 | 712 | 11 | 7 | HP:0000036 | |
| HumanPheno | Dilatation of the renal pelvis | 2.01e-04 | 290 | 11 | 5 | HP:0010946 | |
| HumanPheno | Genital neoplasm | 2.03e-04 | 150 | 11 | 4 | HP:0010787 | |
| HumanPheno | Thick eyebrow | 2.25e-04 | 154 | 11 | 4 | HP:0000574 | |
| HumanPheno | Abnormal subclavian artery morphology | 2.31e-04 | 11 | 11 | 2 | HP:0031251 | |
| HumanPheno | Increased body weight | 2.36e-04 | 491 | 11 | 6 | HP:0004324 | |
| HumanPheno | Abnormal renal pelvis morphology | 2.36e-04 | 300 | 11 | 5 | HP:0010944 | |
| HumanPheno | Abnormal femur morphology | 2.51e-04 | 304 | 11 | 5 | HP:0002823 | |
| HumanPheno | Abnormality of the female genitalia | 2.59e-04 | 741 | 11 | 7 | HP:0010460 | |
| HumanPheno | Abnormal stomach morphology | 2.61e-04 | 742 | 11 | 7 | HP:0002577 | |
| HumanPheno | X-linked dominant inheritance | 2.64e-04 | 62 | 11 | 3 | HP:0001423 | |
| HumanPheno | Duodenal ulcer | 2.77e-04 | 12 | 11 | 2 | HP:0002588 | |
| HumanPheno | Chorioretinal hypopigmentation | 2.77e-04 | 12 | 11 | 2 | HP:0040030 | |
| HumanPheno | Hypoplasia of the phalanges of the toes | 2.77e-04 | 12 | 11 | 2 | HP:0010746 | |
| HumanPheno | Pneumonia | 2.80e-04 | 311 | 11 | 5 | HP:0002090 | |
| HumanPheno | Neoplasm of the gastrointestinal tract | 2.88e-04 | 313 | 11 | 5 | HP:0007378 | |
| HumanPheno | Aggressive behavior | 3.11e-04 | 516 | 11 | 6 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 3.11e-04 | 516 | 11 | 6 | HP:0006919 | |
| HumanPheno | Gastroesophageal reflux | 3.14e-04 | 517 | 11 | 6 | HP:0002020 | |
| HumanPheno | Facial grimacing | 3.26e-04 | 13 | 11 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 3.26e-04 | 13 | 11 | 2 | HP:0010562 | |
| HumanPheno | Abnormality of the thigh | 3.29e-04 | 322 | 11 | 5 | HP:0001439 | |
| HumanPheno | Cryptorchidism | 3.60e-04 | 780 | 11 | 7 | HP:0000028 | |
| HumanPheno | Hypoplastic facial bones | 3.75e-04 | 331 | 11 | 5 | HP:0002692 | |
| HumanPheno | Aplasia/Hypoplasia of facial bones | 3.80e-04 | 332 | 11 | 5 | HP:0034261 | |
| HumanPheno | Duplication of phalanx of hallux | 3.80e-04 | 14 | 11 | 2 | HP:0010066 | |
| HumanPheno | Hypoplastic aortic arch | 3.80e-04 | 14 | 11 | 2 | HP:0012304 | |
| HumanPheno | Parietal foramina | 3.80e-04 | 14 | 11 | 2 | HP:0002697 | |
| HumanPheno | Upslanted palpebral fissure | 3.85e-04 | 333 | 11 | 5 | HP:0000582 | |
| HumanPheno | Deviation of finger | 3.88e-04 | 537 | 11 | 6 | HP:0004097 | |
| HumanPheno | Thin upper lip vermilion | 4.19e-04 | 339 | 11 | 5 | HP:0000219 | |
| HumanPheno | Thin lips | 4.19e-04 | 339 | 11 | 5 | HP:0000213 | |
| HumanPheno | Duplication of phalanx of toe | 4.38e-04 | 15 | 11 | 2 | HP:0010181 | |
| HumanPheno | Social and occupational deterioration | 4.38e-04 | 15 | 11 | 2 | HP:0007086 | |
| HumanPheno | Abnormality of chorioretinal pigmentation | 4.38e-04 | 15 | 11 | 2 | HP:0007661 | |
| HumanPheno | Hyperactivity | 4.79e-04 | 558 | 11 | 6 | HP:0000752 | |
| MousePheno | absent nasal pit | 1.33e-05 | 3 | 30 | 2 | MP:0030060 | |
| MousePheno | abnormal hypothalamus physiology | 2.24e-05 | 26 | 30 | 3 | MP:0005645 | |
| MousePheno | delayed estrous cycle | 6.64e-05 | 6 | 30 | 2 | MP:0009008 | |
| MousePheno | lethality throughout fetal growth and development, incomplete penetrance | 7.32e-05 | 208 | 30 | 5 | MP:0011109 | |
| MousePheno | abnormal face development | 1.59e-04 | 9 | 30 | 2 | MP:0030313 | |
| MousePheno | abnormal nasal pit morphology | 1.59e-04 | 9 | 30 | 2 | MP:0006306 | |
| Domain | - | 2.84e-06 | 2 | 32 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 2.84e-06 | 2 | 32 | 2 | PF02135 | |
| Domain | ZF_TAZ | 2.84e-06 | 2 | 32 | 2 | PS50134 | |
| Domain | Nuc_rcpt_coact_CREBbp | 2.84e-06 | 2 | 32 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 2.84e-06 | 2 | 32 | 2 | PF08214 | |
| Domain | KIX | 2.84e-06 | 2 | 32 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 2.84e-06 | 2 | 32 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 2.84e-06 | 2 | 32 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 2.84e-06 | 2 | 32 | 2 | IPR013178 | |
| Domain | DUF902 | 2.84e-06 | 2 | 32 | 2 | PF06001 | |
| Domain | - | 2.84e-06 | 2 | 32 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 2.84e-06 | 2 | 32 | 2 | IPR010303 | |
| Domain | KAT11 | 2.84e-06 | 2 | 32 | 2 | SM01250 | |
| Domain | - | 2.84e-06 | 2 | 32 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 2.84e-06 | 2 | 32 | 2 | IPR000197 | |
| Domain | KIX_dom | 2.84e-06 | 2 | 32 | 2 | IPR003101 | |
| Domain | Creb_binding | 2.84e-06 | 2 | 32 | 2 | PF09030 | |
| Domain | KIX | 2.84e-06 | 2 | 32 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 2.84e-06 | 2 | 32 | 2 | PS51727 | |
| Domain | - | 8.52e-06 | 3 | 32 | 2 | 1.10.238.110 | |
| Domain | DAG_kinase_N | 8.52e-06 | 3 | 32 | 2 | PF14513 | |
| Domain | DAG_kinase_typeI_N | 8.52e-06 | 3 | 32 | 2 | IPR029477 | |
| Domain | Nuc_rcpt_coact | 4.25e-05 | 6 | 32 | 2 | IPR009110 | |
| Domain | DAGK_acc | 1.27e-04 | 10 | 32 | 2 | PF00609 | |
| Domain | DAGKa | 1.27e-04 | 10 | 32 | 2 | SM00045 | |
| Domain | Diacylglycerol_kin_accessory | 1.27e-04 | 10 | 32 | 2 | IPR000756 | |
| Domain | DAGKc | 2.55e-04 | 14 | 32 | 2 | SM00046 | |
| Domain | DAGK | 2.94e-04 | 15 | 32 | 2 | PS50146 | |
| Domain | Diacylglycerol_kinase_cat_dom | 2.94e-04 | 15 | 32 | 2 | IPR001206 | |
| Domain | DAGK_cat | 2.94e-04 | 15 | 32 | 2 | PF00781 | |
| Domain | NAD/diacylglycerol_kinase | 3.81e-04 | 17 | 32 | 2 | IPR016064 | |
| Domain | ZF_ZZ_2 | 4.28e-04 | 18 | 32 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 4.28e-04 | 18 | 32 | 2 | PS01357 | |
| Domain | ZZ | 4.28e-04 | 18 | 32 | 2 | PF00569 | |
| Domain | Znf_ZZ | 4.78e-04 | 19 | 32 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 4.78e-04 | 19 | 32 | 2 | SM00291 | |
| Domain | Bromodomain_CS | 9.01e-04 | 26 | 32 | 2 | IPR018359 | |
| Domain | SNF2_N | 1.37e-03 | 32 | 32 | 2 | PF00176 | |
| Domain | SNF2_N | 1.37e-03 | 32 | 32 | 2 | IPR000330 | |
| Domain | CHROMO | 1.45e-03 | 33 | 32 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 1.45e-03 | 33 | 32 | 2 | IPR000953 | |
| Domain | BROMODOMAIN_1 | 1.82e-03 | 37 | 32 | 2 | PS00633 | |
| Domain | Bromodomain | 1.92e-03 | 38 | 32 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 2.24e-03 | 41 | 32 | 2 | PS50014 | |
| Domain | BROMO | 2.35e-03 | 42 | 32 | 2 | SM00297 | |
| Domain | Bromodomain | 2.35e-03 | 42 | 32 | 2 | IPR001487 | |
| Domain | - | 2.35e-03 | 42 | 32 | 2 | 1.20.920.10 | |
| Domain | SANT | 3.31e-03 | 50 | 32 | 2 | SM00717 | |
| Domain | SANT/Myb | 3.57e-03 | 52 | 32 | 2 | IPR001005 | |
| Domain | C1_1 | 4.28e-03 | 57 | 32 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 5.37e-03 | 64 | 32 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 5.37e-03 | 64 | 32 | 2 | PS50081 | |
| Domain | C1 | 5.53e-03 | 65 | 32 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 5.70e-03 | 66 | 32 | 2 | IPR002219 | |
| Domain | - | 6.06e-03 | 218 | 32 | 3 | 1.10.10.10 | |
| Domain | WHTH_DNA-bd_dom | 8.08e-03 | 242 | 32 | 3 | IPR011991 | |
| Domain | Collagen | 9.29e-03 | 85 | 32 | 2 | PF01391 | |
| Domain | Collagen | 9.29e-03 | 85 | 32 | 2 | IPR008160 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.52e-06 | 301 | 28 | 7 | MM15983 | |
| Pathway | PID_AR_TF_PATHWAY | 3.41e-06 | 53 | 28 | 4 | M151 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.05e-05 | 22 | 28 | 3 | MM1370 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.38e-05 | 24 | 28 | 3 | M13404 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 3.79e-05 | 5 | 28 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 3.79e-05 | 5 | 28 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 3.79e-05 | 5 | 28 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 3.79e-05 | 5 | 28 | 2 | M48023 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.21e-05 | 37 | 28 | 3 | M27797 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 5.68e-05 | 6 | 28 | 2 | M22062 | |
| Pathway | PID_FOXM1_PATHWAY | 6.60e-05 | 40 | 28 | 3 | M176 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 7.65e-05 | 42 | 28 | 3 | M48237 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 7.65e-05 | 42 | 28 | 3 | M17541 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.94e-05 | 7 | 28 | 2 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.06e-04 | 8 | 28 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.06e-04 | 8 | 28 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.06e-04 | 8 | 28 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.06e-04 | 8 | 28 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.36e-04 | 9 | 28 | 2 | M47451 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.46e-04 | 137 | 28 | 4 | M48232 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.70e-04 | 10 | 28 | 2 | M27945 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.07e-04 | 11 | 28 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 2.07e-04 | 11 | 28 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 2.07e-04 | 11 | 28 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.48e-04 | 12 | 28 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.48e-04 | 12 | 28 | 2 | M27765 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.82e-04 | 65 | 28 | 3 | M39682 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.41e-04 | 14 | 28 | 2 | M27808 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 3.93e-04 | 15 | 28 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 3.93e-04 | 15 | 28 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.93e-04 | 15 | 28 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 3.93e-04 | 15 | 28 | 2 | M953 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 4.49e-04 | 16 | 28 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 4.49e-04 | 16 | 28 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 4.49e-04 | 16 | 28 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 4.49e-04 | 16 | 28 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 4.49e-04 | 16 | 28 | 2 | M27940 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 5.08e-04 | 17 | 28 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 5.08e-04 | 17 | 28 | 2 | M48025 | |
| Pathway | PID_REG_GR_PATHWAY | 5.60e-04 | 82 | 28 | 3 | M115 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 5.71e-04 | 18 | 28 | 2 | M26942 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 6.37e-04 | 19 | 28 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 6.37e-04 | 19 | 28 | 2 | M46442 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 6.43e-04 | 86 | 28 | 3 | M39375 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.07e-04 | 20 | 28 | 2 | M27881 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 7.58e-04 | 91 | 28 | 3 | M27101 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 7.58e-04 | 91 | 28 | 3 | M39700 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 7.81e-04 | 21 | 28 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 7.81e-04 | 21 | 28 | 2 | M27485 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 8.57e-04 | 22 | 28 | 2 | MM1443 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 8.60e-04 | 95 | 28 | 3 | M48268 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 9.13e-04 | 97 | 28 | 3 | M48262 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 9.38e-04 | 23 | 28 | 2 | M2821 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.11e-03 | 25 | 28 | 2 | M27880 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.11e-03 | 25 | 28 | 2 | MM14511 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.16e-03 | 237 | 28 | 4 | M27786 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.20e-03 | 26 | 28 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 1.20e-03 | 26 | 28 | 2 | M32 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.20e-03 | 26 | 28 | 2 | MM14793 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.29e-03 | 27 | 28 | 2 | M12123 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.39e-03 | 28 | 28 | 2 | M27254 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.49e-03 | 29 | 28 | 2 | M48076 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.50e-03 | 254 | 28 | 4 | M27131 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.60e-03 | 30 | 28 | 2 | M207 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.60e-03 | 30 | 28 | 2 | M936 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.71e-03 | 31 | 28 | 2 | M39522 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.77e-03 | 122 | 28 | 3 | M29689 | |
| Pathway | PID_IL12_STAT4_PATHWAY | 1.82e-03 | 32 | 28 | 2 | M290 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.82e-03 | 32 | 28 | 2 | M39521 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.93e-03 | 272 | 28 | 4 | M29619 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 2.05e-03 | 34 | 28 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 2.05e-03 | 34 | 28 | 2 | M44 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.05e-03 | 34 | 28 | 2 | MM15531 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.06e-03 | 277 | 28 | 4 | MM15414 | |
| Pathway | REACTOME_GASTRULATION | 2.07e-03 | 129 | 28 | 3 | M46433 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 2.17e-03 | 35 | 28 | 2 | M48246 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.17e-03 | 35 | 28 | 2 | M47969 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.23e-03 | 283 | 28 | 4 | M13087 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.56e-03 | 38 | 28 | 2 | M27757 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.56e-03 | 38 | 28 | 2 | M27255 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 2.73e-03 | 142 | 28 | 3 | M48257 | |
| Pathway | PID_IFNG_PATHWAY | 2.83e-03 | 40 | 28 | 2 | M161 | |
| Pathway | WP_MALE_INFERTILITY | 2.89e-03 | 145 | 28 | 3 | M39856 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 3.24e-03 | 151 | 28 | 3 | M19428 | |
| Pathway | PID_HNF3A_PATHWAY | 3.42e-03 | 44 | 28 | 2 | M285 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.42e-03 | 44 | 28 | 2 | M27295 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.89e-03 | 47 | 28 | 2 | M7946 | |
| Pathway | PID_HES_HEY_PATHWAY | 4.06e-03 | 48 | 28 | 2 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.06e-03 | 48 | 28 | 2 | M611 | |
| Pathway | PID_FOXO_PATHWAY | 4.22e-03 | 49 | 28 | 2 | M136 | |
| Pathway | REACTOME_HEME_SIGNALING | 4.22e-03 | 49 | 28 | 2 | M41832 | |
| Pathway | KEGG_GLYCEROLIPID_METABOLISM | 4.22e-03 | 49 | 28 | 2 | M15902 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.22e-03 | 49 | 28 | 2 | M618 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 4.74e-03 | 52 | 28 | 2 | M2404 | |
| Pathway | PID_NFAT_3PATHWAY | 4.92e-03 | 53 | 28 | 2 | M113 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 4.92e-03 | 53 | 28 | 2 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 5.29e-03 | 55 | 28 | 2 | M39351 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 5.40e-03 | 1432 | 28 | 8 | M509 | |
| Pathway | WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES | 5.68e-03 | 57 | 28 | 2 | M39877 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 5.87e-03 | 58 | 28 | 2 | M29616 | |
| Pubmed | ZNF512B DACH1 SMARCC1 ETV5 BCL9L ARID1B CHD7 PAX6 FAM120A ATRX TCERG1 SS18 RBM33 CREBBP WDR33 EP300 ZMIZ2 PRRC2B | 2.74e-17 | 1429 | 32 | 18 | 35140242 | |
| Pubmed | DACH1 SMARCC1 ETV5 ATXN2L ARID1B CHD7 FAM120A SNRPA TCERG1 RBM33 CREBBP SF1 EP300 ZMIZ2 PRRC2B | 1.03e-14 | 1103 | 32 | 15 | 34189442 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF512B DACH1 SMARCC1 ATXN2L ARID1B CHD7 SNRPA ATRX TCERG1 SS18 RBM33 WDR33 SF1 | 9.85e-13 | 954 | 32 | 13 | 36373674 |
| Pubmed | 1.06e-12 | 152 | 32 | 8 | 38360978 | ||
| Pubmed | 1.38e-12 | 157 | 32 | 8 | 30186101 | ||
| Pubmed | 2.01e-12 | 268 | 32 | 9 | 33640491 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.24e-11 | 351 | 32 | 9 | 38297188 | |
| Pubmed | DACH1 SMARCC1 ATXN2L ARID1B TCERG1 CREBBP WDR33 EP300 PRRC2B | 1.16e-09 | 549 | 32 | 9 | 38280479 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 6.67e-09 | 457 | 32 | 8 | 32344865 | |
| Pubmed | 1.31e-08 | 83 | 32 | 5 | 28794006 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 7607687 | ||
| Pubmed | 2.47e-08 | 7 | 32 | 3 | 23540691 | ||
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 2.47e-08 | 7 | 32 | 3 | 9590696 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.68e-08 | 588 | 32 | 8 | 38580884 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 5.27e-08 | 40 | 32 | 4 | 34585037 | |
| Pubmed | 6.52e-08 | 399 | 32 | 7 | 35987950 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 8.45e-08 | 10 | 32 | 3 | 16751102 | |
| Pubmed | 1.00e-07 | 425 | 32 | 7 | 24999758 | ||
| Pubmed | CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder. | 1.16e-07 | 11 | 32 | 3 | 36385105 | |
| Pubmed | 1.16e-07 | 11 | 32 | 3 | 24038357 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.50e-07 | 1294 | 32 | 10 | 30804502 | |
| Pubmed | 1.55e-07 | 12 | 32 | 3 | 11734557 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.09e-07 | 283 | 32 | 6 | 30585729 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.92e-07 | 154 | 32 | 5 | 16055720 | |
| Pubmed | 3.19e-07 | 15 | 32 | 3 | 23785148 | ||
| Pubmed | 3.84e-07 | 65 | 32 | 4 | 26655900 | ||
| Pubmed | A human RNA polymerase II complex containing factors that modify chromatin structure. | 3.93e-07 | 16 | 32 | 3 | 9710619 | |
| Pubmed | 4.09e-07 | 66 | 32 | 4 | 23275444 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 5.21e-07 | 807 | 32 | 8 | 22681889 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 6.31e-07 | 180 | 32 | 5 | 30110629 | |
| Pubmed | 7.98e-07 | 20 | 32 | 3 | 34220450 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 8.20e-07 | 2 | 32 | 2 | 34845315 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 19729597 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 15860545 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 8.20e-07 | 2 | 32 | 2 | 24551300 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 33911074 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 9018065 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 24648406 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 30135524 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 8.20e-07 | 2 | 32 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 8.20e-07 | 2 | 32 | 2 | 29217654 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 20717166 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 8.20e-07 | 2 | 32 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 8.20e-07 | 2 | 32 | 2 | 29170789 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 25893291 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 11559821 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 8.20e-07 | 2 | 32 | 2 | 12646247 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 32576962 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 19822209 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 9651501 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 24522976 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 8.20e-07 | 2 | 32 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 8.20e-07 | 2 | 32 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 8.20e-07 | 2 | 32 | 2 | 34813504 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 8.20e-07 | 2 | 32 | 2 | 12696060 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 11030627 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 8.20e-07 | 2 | 32 | 2 | 36109165 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 24639469 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 37816914 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 12242694 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 8.20e-07 | 2 | 32 | 2 | 11438528 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 10918613 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 31182547 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 35502657 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 30635043 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 31898871 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 8.20e-07 | 2 | 32 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 8.20e-07 | 2 | 32 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 8.20e-07 | 2 | 32 | 2 | 27881443 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 19272189 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 8.20e-07 | 2 | 32 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 8.20e-07 | 2 | 32 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 8.20e-07 | 2 | 32 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 8.20e-07 | 2 | 32 | 2 | 32690000 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 9733868 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 30953353 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 21803292 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 9811832 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 24089570 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 8.20e-07 | 2 | 32 | 2 | 33063428 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 34506759 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 22177454 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 8.20e-07 | 2 | 32 | 2 | 39266679 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 22303793 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 8.20e-07 | 2 | 32 | 2 | 34019788 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.14e-06 | 203 | 32 | 5 | 22083510 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 1.24e-06 | 23 | 32 | 3 | 30962207 | |
| Pubmed | 1.41e-06 | 24 | 32 | 3 | 24946904 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.52e-06 | 398 | 32 | 6 | 35016035 | |
| Interaction | SP7 interactions | SMARCC1 BCL9L ARID1B CHD7 TCERG1 SS18 RBM33 CREBBP WDR33 EP300 ZMIZ2 PRRC2B | 1.22e-14 | 304 | 31 | 12 | int:SP7 |
| Interaction | CRX interactions | ZNF512B SMARCC1 BCL9L ARID1B CHD7 MYO15B CREBBP EP300 ZMIZ2 PRRC2B | 2.98e-12 | 254 | 31 | 10 | int:CRX |
| Interaction | AR interactions | ZNF512B SMARCC1 ETV5 BCL9L ARID1B CHD7 PAX6 ATRX RBM33 CREBBP WDR33 EP300 ZMIZ2 PRRC2B | 5.42e-11 | 992 | 31 | 14 | int:AR |
| Interaction | CEBPA interactions | DACH1 SMARCC1 ETV5 ATXN2L ARID1B CHD7 FAM120A SNRPA TCERG1 RBM33 CREBBP SF1 EP300 ZMIZ2 PRRC2B | 7.88e-11 | 1245 | 31 | 15 | int:CEBPA |
| Interaction | SS18L1 interactions | 1.24e-10 | 98 | 31 | 7 | int:SS18L1 | |
| Interaction | EGR2 interactions | 1.52e-10 | 171 | 31 | 8 | int:EGR2 | |
| Interaction | HNF1B interactions | 3.53e-10 | 190 | 31 | 8 | int:HNF1B | |
| Interaction | FEV interactions | 5.97e-10 | 203 | 31 | 8 | int:FEV | |
| Interaction | GCM1 interactions | 8.11e-10 | 68 | 31 | 6 | int:GCM1 | |
| Interaction | SMC5 interactions | ZNF512B DACH1 SMARCC1 ATXN2L ARID1B CHD7 SNRPA ATRX TCERG1 SS18 RBM33 WDR33 SF1 | 9.17e-10 | 1000 | 31 | 13 | int:SMC5 |
| Interaction | EYA4 interactions | 2.47e-09 | 243 | 31 | 8 | int:EYA4 | |
| Interaction | SOX7 interactions | 2.56e-09 | 82 | 31 | 6 | int:SOX7 | |
| Interaction | PAX6 interactions | 2.76e-09 | 366 | 31 | 9 | int:PAX6 | |
| Interaction | IRF4 interactions | 3.18e-09 | 85 | 31 | 6 | int:IRF4 | |
| Interaction | HNF4A interactions | 6.53e-09 | 275 | 31 | 8 | int:HNF4A | |
| Interaction | SOX9 interactions | 7.10e-09 | 97 | 31 | 6 | int:SOX9 | |
| Interaction | SUPT5H interactions | 7.11e-09 | 408 | 31 | 9 | int:SUPT5H | |
| Interaction | FUS interactions | DGKA SMARCC1 ATXN2L FAM120A SNRPA TCERG1 SS18 CREBBP WDR33 SF1 EP300 | 8.32e-09 | 757 | 31 | 11 | int:FUS |
| Interaction | ALG13 interactions | 9.93e-09 | 183 | 31 | 7 | int:ALG13 | |
| Interaction | LHX2 interactions | 9.93e-09 | 183 | 31 | 7 | int:LHX2 | |
| Interaction | GATA2 interactions | 1.77e-08 | 199 | 31 | 7 | int:GATA2 | |
| Interaction | TBXT interactions | 2.09e-08 | 116 | 31 | 6 | int:TBXT | |
| Interaction | PAX7 interactions | 3.12e-08 | 124 | 31 | 6 | int:PAX7 | |
| Interaction | ERG interactions | 3.88e-08 | 223 | 31 | 7 | int:ERG | |
| Interaction | ETV4 interactions | 6.44e-08 | 69 | 31 | 5 | int:ETV4 | |
| Interaction | ARID2 interactions | 1.09e-07 | 153 | 31 | 6 | int:ARID2 | |
| Interaction | ARID1A interactions | 1.66e-07 | 276 | 31 | 7 | int:ARID1A | |
| Interaction | NUP35 interactions | 1.85e-07 | 424 | 31 | 8 | int:NUP35 | |
| Interaction | SMARCE1 interactions | 2.17e-07 | 287 | 31 | 7 | int:SMARCE1 | |
| Interaction | TLX1 interactions | 2.42e-07 | 175 | 31 | 6 | int:TLX1 | |
| Interaction | HOXB2 interactions | 2.61e-07 | 36 | 31 | 4 | int:HOXB2 | |
| Interaction | DPF1 interactions | 3.23e-07 | 95 | 31 | 5 | int:DPF1 | |
| Interaction | SMARCA4 interactions | 3.56e-07 | 462 | 31 | 8 | int:SMARCA4 | |
| Interaction | GATA3 interactions | 3.58e-07 | 187 | 31 | 6 | int:GATA3 | |
| Interaction | YAP1 interactions | DACH1 SMARCC1 BCL9L ATXN2L ARID1B FAM120A TCERG1 NFAT5 CREBBP WDR33 EP300 | 3.59e-07 | 1095 | 31 | 11 | int:YAP1 |
| Interaction | ING1 interactions | 4.83e-07 | 103 | 31 | 5 | int:ING1 | |
| Interaction | SOX2 interactions | DACH1 SMARCC1 BCL9L ATXN2L ARID1B CHD7 PAX6 FAM120A SS18 EP300 ZMIZ2 PRRC2B | 5.81e-07 | 1422 | 31 | 12 | int:SOX2 |
| Interaction | PAX8 interactions | 7.02e-07 | 111 | 31 | 5 | int:PAX8 | |
| Interaction | SMARCC2 interactions | 8.73e-07 | 353 | 31 | 7 | int:SMARCC2 | |
| Interaction | DDIT3 interactions | 1.03e-06 | 120 | 31 | 5 | int:DDIT3 | |
| Interaction | TERF2IP interactions | 1.36e-06 | 552 | 31 | 8 | int:TERF2IP | |
| Interaction | SMARCC1 interactions | 1.53e-06 | 384 | 31 | 7 | int:SMARCC1 | |
| Interaction | PAX9 interactions | 1.54e-06 | 130 | 31 | 5 | int:PAX9 | |
| Interaction | MECP2 interactions | ZNF512B SMARCC1 ATXN2L ARID1B CHD7 SNRPA ATRX TCERG1 WDR33 SF1 EP300 | 1.78e-06 | 1287 | 31 | 11 | int:MECP2 |
| Interaction | ASF1A interactions | 1.90e-06 | 249 | 31 | 6 | int:ASF1A | |
| Interaction | PBRM1 interactions | 2.34e-06 | 258 | 31 | 6 | int:PBRM1 | |
| Interaction | DAZL interactions | 2.63e-06 | 145 | 31 | 5 | int:DAZL | |
| Interaction | ELF5 interactions | 2.81e-06 | 147 | 31 | 5 | int:ELF5 | |
| Interaction | WWTR1 interactions | 2.86e-06 | 422 | 31 | 7 | int:WWTR1 | |
| Interaction | BICRA interactions | 3.28e-06 | 67 | 31 | 4 | int:BICRA | |
| Interaction | MYCN interactions | ZNF512B SMARCC1 ATXN2L ARID1B CHD7 FAM120A SNRPA SS18 SF1 EP300 PRRC2B | 3.35e-06 | 1373 | 31 | 11 | int:MYCN |
| Interaction | FBLN5 interactions | 4.13e-06 | 159 | 31 | 5 | int:FBLN5 | |
| Interaction | SMAD3 interactions | 4.18e-06 | 447 | 31 | 7 | int:SMAD3 | |
| Interaction | HOXB4 interactions | 4.30e-06 | 21 | 31 | 3 | int:HOXB4 | |
| Interaction | RBBP5 interactions | 4.32e-06 | 287 | 31 | 6 | int:RBBP5 | |
| Interaction | CELF1 interactions | 4.41e-06 | 288 | 31 | 6 | int:CELF1 | |
| Interaction | DDX3X interactions | 4.64e-06 | 651 | 31 | 8 | int:DDX3X | |
| Interaction | TLX3 interactions | 4.68e-06 | 291 | 31 | 6 | int:TLX3 | |
| Interaction | BMI1 interactions | 5.07e-06 | 659 | 31 | 8 | int:BMI1 | |
| Interaction | FUBP3 interactions | 5.26e-06 | 297 | 31 | 6 | int:FUBP3 | |
| Interaction | TEAD1 interactions | 6.78e-06 | 176 | 31 | 5 | int:TEAD1 | |
| Interaction | FOS interactions | 6.97e-06 | 312 | 31 | 6 | int:FOS | |
| Interaction | ARID1B interactions | 6.97e-06 | 177 | 31 | 5 | int:ARID1B | |
| Interaction | BRDT interactions | 7.02e-06 | 81 | 31 | 4 | int:BRDT | |
| Interaction | XRCC6 interactions | 7.22e-06 | 928 | 31 | 9 | int:XRCC6 | |
| Interaction | IRF1 interactions | 7.73e-06 | 83 | 31 | 4 | int:IRF1 | |
| Interaction | SMG7 interactions | 7.91e-06 | 319 | 31 | 6 | int:SMG7 | |
| Interaction | CDX2 interactions | 8.91e-06 | 86 | 31 | 4 | int:CDX2 | |
| Interaction | GSC interactions | 9.33e-06 | 87 | 31 | 4 | int:GSC | |
| Interaction | SS18 interactions | 9.76e-06 | 88 | 31 | 4 | int:SS18 | |
| Interaction | MYOD1 interactions | 1.09e-05 | 194 | 31 | 5 | int:MYOD1 | |
| Interaction | KLF5 interactions | 1.12e-05 | 195 | 31 | 5 | int:KLF5 | |
| Interaction | SOX10 interactions | 1.16e-05 | 92 | 31 | 4 | int:SOX10 | |
| Interaction | PAPOLA interactions | 1.16e-05 | 92 | 31 | 4 | int:PAPOLA | |
| Interaction | SMARCA2 interactions | 1.26e-05 | 346 | 31 | 6 | int:SMARCA2 | |
| Interaction | SNW1 interactions | 1.27e-05 | 747 | 31 | 8 | int:SNW1 | |
| Interaction | DPF2 interactions | 1.32e-05 | 349 | 31 | 6 | int:DPF2 | |
| Interaction | DPF3 interactions | 1.32e-05 | 95 | 31 | 4 | int:DPF3 | |
| Interaction | BCL7B interactions | 1.32e-05 | 95 | 31 | 4 | int:BCL7B | |
| Interaction | SRSF11 interactions | 1.36e-05 | 203 | 31 | 5 | int:SRSF11 | |
| Interaction | CHD3 interactions | 1.40e-05 | 757 | 31 | 8 | int:CHD3 | |
| Interaction | E2F4 interactions | 1.43e-05 | 540 | 31 | 7 | int:E2F4 | |
| Interaction | NONO interactions | 1.60e-05 | 549 | 31 | 7 | int:NONO | |
| Interaction | NCOR1 interactions | 1.65e-05 | 363 | 31 | 6 | int:NCOR1 | |
| Interaction | SMARCB1 interactions | 1.67e-05 | 364 | 31 | 6 | int:SMARCB1 | |
| Interaction | TLE3 interactions | 2.01e-05 | 376 | 31 | 6 | int:TLE3 | |
| Interaction | SLX4 interactions | 2.08e-05 | 572 | 31 | 7 | int:SLX4 | |
| Interaction | SMARCD3 interactions | 2.12e-05 | 107 | 31 | 4 | int:SMARCD3 | |
| Interaction | SIN3A interactions | 2.13e-05 | 380 | 31 | 6 | int:SIN3A | |
| Interaction | NCOA3 interactions | 2.18e-05 | 224 | 31 | 5 | int:NCOA3 | |
| Interaction | GATAD2A interactions | 2.18e-05 | 224 | 31 | 5 | int:GATAD2A | |
| Interaction | E2F5 interactions | 2.27e-05 | 36 | 31 | 3 | int:E2F5 | |
| Interaction | WBP4 interactions | 2.28e-05 | 109 | 31 | 4 | int:WBP4 | |
| Interaction | EN1 interactions | 2.36e-05 | 110 | 31 | 4 | int:EN1 | |
| Interaction | POU5F1 interactions | 2.38e-05 | 584 | 31 | 7 | int:POU5F1 | |
| Interaction | KLF1 interactions | 2.47e-05 | 37 | 31 | 3 | int:KLF1 | |
| Interaction | RANBP3 interactions | 2.53e-05 | 112 | 31 | 4 | int:RANBP3 | |
| Interaction | TBR1 interactions | 2.62e-05 | 113 | 31 | 4 | int:TBR1 | |
| Interaction | FHL2 interactions | 2.69e-05 | 396 | 31 | 6 | int:FHL2 | |
| Interaction | CREBBP interactions | 2.80e-05 | 599 | 31 | 7 | int:CREBBP | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q27 | 3.62e-03 | 128 | 32 | 2 | chr3q27 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 5.20e-05 | 10 | 20 | 2 | 1178 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.57e-04 | 17 | 20 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.76e-04 | 18 | 20 | 2 | 91 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.55e-03 | 53 | 20 | 2 | 532 | |
| GeneFamily | RNA binding motif containing | 2.28e-02 | 213 | 20 | 2 | 725 | |
| GeneFamily | EF-hand domain containing | 2.40e-02 | 219 | 20 | 2 | 863 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.54e-08 | 180 | 32 | 6 | M8239 | |
| Coexpression | ASTON_MAJOR_DEPRESSIVE_DISORDER_DN | 4.21e-05 | 160 | 32 | 4 | M11011 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | 5.21e-05 | 1492 | 32 | 9 | M40023 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_UP | 6.23e-05 | 177 | 32 | 4 | M9118 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_UP | 8.55e-05 | 192 | 32 | 4 | MM752 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | 9.03e-05 | 905 | 32 | 7 | M40865 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 9.81e-05 | 199 | 32 | 4 | M7319 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN | 1.00e-04 | 200 | 32 | 4 | M8040 | |
| Coexpression | GSE17721_0.5H_VS_8H_CPG_BMDC_UP | 1.00e-04 | 200 | 32 | 4 | M4126 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 1.04e-04 | 634 | 32 | 6 | M40866 | |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_COMPLETE | 1.55e-04 | 224 | 32 | 4 | M2500 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.66e-04 | 432 | 32 | 5 | M41149 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 6.52e-05 | 989 | 31 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500 | 6.68e-05 | 491 | 31 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 7.22e-05 | 498 | 31 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#1 | 1.57e-04 | 72 | 31 | 3 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K1 | |
| CoexpressionAtlas | e9.5_OlfacPlacod_top-relative-expression-ranked_100 | 1.70e-04 | 74 | 31 | 3 | Facebase_ST1_e9.5_OlfacPlacod_100 | |
| CoexpressionAtlas | e9.5_NeuroEpith_OverFaceMesench_top-relative-expression-ranked_500_2 | 1.72e-04 | 193 | 31 | 4 | Facebase_ST1_e9.5_NeuroEpith_OverFaceMesench_500_2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.37e-04 | 210 | 31 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.37e-04 | 210 | 31 | 4 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.24e-04 | 92 | 31 | 3 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.35e-04 | 230 | 31 | 4 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_100 | 3.79e-04 | 97 | 31 | 3 | Facebase_RNAseq_e9.5_Maxillary Arch_100 | |
| CoexpressionAtlas | e10.5_NeuroEpith_MedialEmin_top-relative-expression-ranked_500_2 | 4.07e-04 | 242 | 31 | 4 | Facebase_ST1_e10.5_NeuroEpith_MedialEmin_500_2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_100 | 4.14e-04 | 100 | 31 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#2 | 4.14e-04 | 100 | 31 | 3 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 4.15e-04 | 973 | 31 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | 4.42e-04 | 983 | 31 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.53e-04 | 249 | 31 | 4 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500 | 6.57e-04 | 489 | 31 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | 6.95e-04 | 495 | 31 | 5 | Facebase_RNAseq_e8.5_Floor Plate_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | 6.95e-04 | 495 | 31 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 7.01e-04 | 496 | 31 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.13e-04 | 281 | 31 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | e9.5_OlfacPlacod_top-relative-expression-ranked_500 | 7.32e-04 | 283 | 31 | 4 | Facebase_ST1_e9.5_OlfacPlacod_500 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.29e-06 | 186 | 32 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-05 | 192 | 32 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.07e-05 | 193 | 32 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-05 | 199 | 32 | 4 | 8e72efcd421639ac36ed036ee13f13de070d361f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-05 | 200 | 32 | 4 | 4a57d6ba1531ce4e263daccd5de487977e6a1fdd | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-05 | 200 | 32 | 4 | b706526b9c3485889a31253a1ffd017ad3f3fddc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related-Oligodendrocyte/OPC|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-05 | 200 | 32 | 4 | 7557ea33c3d080d0fa4ca0c2703279932d01e6d0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-05 | 200 | 32 | 4 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Stem_cells|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-05 | 200 | 32 | 4 | 474e6ab48f199315f3cca86b81fdf54e0461b7b8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-05 | 200 | 32 | 4 | 3dcaeb9f1e387784c299bfe0da1516598f82edf5 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-05 | 200 | 32 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Stem_cells-Stem_cells|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-05 | 200 | 32 | 4 | 01a29651e9bb64ef7666c6a61ec396eeb88b2816 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-OPC_related-Oligodendrocyte/OPC|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.43e-04 | 142 | 32 | 3 | 43e72e4b9ae33768672ef90c8bbfd2ca1818c746 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-OPC_related|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.43e-04 | 142 | 32 | 3 | d2d150e3019a5b7b143e50b1c1c2b6764abf36bf | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 142 | 32 | 3 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 142 | 32 | 3 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-04 | 151 | 32 | 3 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | BL-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.10e-04 | 162 | 32 | 3 | 25ec9df914445b4daae4fd28fd0e60b64797c46d | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 2.10e-04 | 162 | 32 | 3 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-04 | 165 | 32 | 3 | e381bcd558745f3a60346f78b49d0b2672184baa | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-04 | 166 | 32 | 3 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-GMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.26e-04 | 166 | 32 | 3 | d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-04 | 168 | 32 | 3 | 217770a94ace446cdfc7687b459dece707576e76 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 170 | 32 | 3 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-04 | 170 | 32 | 3 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 2.43e-04 | 170 | 32 | 3 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-04 | 173 | 32 | 3 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-04 | 173 | 32 | 3 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-04 | 173 | 32 | 3 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-04 | 174 | 32 | 3 | 43c0e758fa8683708475aec846929ac70d41d7f5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-04 | 174 | 32 | 3 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-04 | 174 | 32 | 3 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-04 | 176 | 32 | 3 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-04 | 177 | 32 | 3 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-04 | 181 | 32 | 3 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | Hippocampus-Macroglia|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.06e-04 | 184 | 32 | 3 | a1d039ddf1e2a87b870f3ce6d139be56090349df | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-04 | 184 | 32 | 3 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 184 | 32 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-04 | 185 | 32 | 3 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.21e-04 | 187 | 32 | 3 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.26e-04 | 188 | 32 | 3 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-04 | 188 | 32 | 3 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-04 | 189 | 32 | 3 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-04 | 189 | 32 | 3 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-04 | 189 | 32 | 3 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-04 | 189 | 32 | 3 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 3.36e-04 | 190 | 32 | 3 | 0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-04 | 190 | 32 | 3 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.36e-04 | 190 | 32 | 3 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-04 | 190 | 32 | 3 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-04 | 190 | 32 | 3 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-04 | 191 | 32 | 3 | 2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-04 | 191 | 32 | 3 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-04 | 191 | 32 | 3 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-04 | 191 | 32 | 3 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-04 | 191 | 32 | 3 | 48cffb55c71bb8b34e926fc461fcd345ce43ea00 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-04 | 191 | 32 | 3 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 3.46e-04 | 192 | 32 | 3 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.52e-04 | 193 | 32 | 3 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.52e-04 | 193 | 32 | 3 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.52e-04 | 193 | 32 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-04 | 194 | 32 | 3 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 194 | 32 | 3 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.62e-04 | 195 | 32 | 3 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.62e-04 | 195 | 32 | 3 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 195 | 32 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-04 | 195 | 32 | 3 | da8680a91648843901e456b5faef5e85039ade15 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-04 | 195 | 32 | 3 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 195 | 32 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.62e-04 | 195 | 32 | 3 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.62e-04 | 195 | 32 | 3 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 196 | 32 | 3 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.73e-04 | 197 | 32 | 3 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | COVID-19_Severe-CD4+_T_naive|COVID-19_Severe / Disease condition and Cell class | 3.73e-04 | 197 | 32 | 3 | ac26672bd2cb3bc9a11206d8da203bafec3931f6 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new|World / Primary Cells by Cluster | 3.79e-04 | 198 | 32 | 3 | 11d2d4d179bc31ef2897d7ceeaf9bed1b20cbdc0 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new-9|World / Primary Cells by Cluster | 3.79e-04 | 198 | 32 | 3 | c724ef958e14e17a7d8c02b9f842510c0780f635 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.79e-04 | 198 | 32 | 3 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | T_cells-CCR7+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.85e-04 | 199 | 32 | 3 | 467820d6abe3024d9d655b9672c2f9cdc1303db3 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Radial_glial-oRG|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.85e-04 | 199 | 32 | 3 | 151bda6821b52cfb4491474892ecb45781522837 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 3.85e-04 | 199 | 32 | 3 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.85e-04 | 199 | 32 | 3 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.85e-04 | 199 | 32 | 3 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related-Oligodendrocyte/OPC|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 345f1eac498cc87fd7bf08e7312608b2d6fe1dd7 | |
| ToppCell | (3)_ILC|World / shred on Cell_type and subtype | 3.90e-04 | 200 | 32 | 3 | 03554b3f323785b1e0b48fa32de0d92065dd798e | |
| ToppCell | Transverse-(3)_ILC-(30)_ILC|Transverse / shred on region, Cell_type, and subtype | 3.90e-04 | 200 | 32 | 3 | 528520dc98775aca6cc7568fedf5906ea55e0bea | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Transverse-(3)_ILC|Transverse / shred on region, Cell_type, and subtype | 3.90e-04 | 200 | 32 | 3 | c1ad7cb012e1c8911e417f7d64ca662c4f5010e0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | c792d1dbbe27ebd60f4770834f30882c1a625be5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial-Astrocyte|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 98d7f577b31a603bf835bf9b4ea31999445cf0e5 | |
| ToppCell | Transverse-ILC|Transverse / Region, Cell class and subclass | 3.90e-04 | 200 | 32 | 3 | eb04d6ad2270d3d9ac3d1fae1bb9bedc6fca38fe | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 8f5d98f962ddd8c4658c89ff8a2894de1228562a | |
| ToppCell | Transverse-ILC-ILC|Transverse / Region, Cell class and subclass | 3.90e-04 | 200 | 32 | 3 | 60ec185df2f1989bf8febf75b11c46a576829be3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_3|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 55a1df656545ff078b727d55e4d65d61ddb5c41f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 38b51f337e183011e3ff32997ec26d8a424c6b78 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Neuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | b5019b9d48f32cffd4645a5c0f3e0ac504ea8019 | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 6.12e-06 | 188 | 32 | 5 | 4835_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 7.12e-06 | 194 | 32 | 5 | 3903_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 7.49e-06 | 196 | 32 | 5 | 2667_DN | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 7.68e-06 | 197 | 32 | 5 | 2837_DN | |
| Drug | Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 7.68e-06 | 197 | 32 | 5 | 3299_UP | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; HL60; HT_HG-U133A | 7.87e-06 | 198 | 32 | 5 | 3038_DN | |
| Drug | CP-944629 [668990-94-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.26e-06 | 200 | 32 | 5 | 7544_DN | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 1.91e-05 | 5 | 32 | 2 | ctd:C575894 | |
| Drug | cerous chloride | 1.07e-04 | 177 | 32 | 4 | ctd:C026690 | |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; HL60; HT_HG-U133A | 1.17e-04 | 181 | 32 | 4 | 3106_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.32e-04 | 187 | 32 | 4 | 4302_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.38e-04 | 189 | 32 | 4 | 4271_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.41e-04 | 190 | 32 | 4 | 3373_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.44e-04 | 191 | 32 | 4 | 4303_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.44e-04 | 191 | 32 | 4 | 3926_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.44e-04 | 191 | 32 | 4 | 6028_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.44e-04 | 191 | 32 | 4 | 6020_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.44e-04 | 191 | 32 | 4 | 4273_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; HL60; HT_HG-U133A | 1.49e-04 | 193 | 32 | 4 | 2477_DN | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 3377_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 4361_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 4312_DN | |
| Drug | 5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA | 1.55e-04 | 195 | 32 | 4 | 843_DN | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 2649_DN | |
| Drug | Condelphine [7633-69-4]; Down 200; 8.8uM; HL60; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 2976_DN | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; HL60; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 1841_DN | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 4389_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 3872_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; HL60; HG-U133A | 1.59e-04 | 196 | 32 | 4 | 1367_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 2128_DN | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 4134_UP | |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 4103_UP | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; PC3; HG-U133A | 1.65e-04 | 198 | 32 | 4 | 1938_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 3223_UP | |
| Drug | R59022 | 1.65e-04 | 76 | 32 | 3 | CID000003012 | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 7398_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 2408_UP | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; HL60; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 2388_UP | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 4687_DN | |
| Drug | Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 7404_UP | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 1165_DN | |
| Drug | AC1L4Q08 | 1.99e-04 | 15 | 32 | 2 | CID000161747 | |
| Drug | AC1L1BXF | 2.30e-04 | 85 | 32 | 3 | CID000001650 | |
| Disease | Menke-Hennekam syndrome | 1.14e-06 | 2 | 32 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 1.14e-06 | 2 | 32 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 1.14e-06 | 2 | 32 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.14e-06 | 2 | 32 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 1.14e-06 | 2 | 32 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.14e-06 | 2 | 32 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 1.14e-06 | 2 | 32 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi Syndrome | 1.14e-06 | 2 | 32 | 2 | C0035934 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.75e-05 | 195 | 32 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | ischemia (implicated_via_orthology) | 1.53e-04 | 17 | 32 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 1.74e-04 | 100 | 32 | 3 | C0010606 | |
| Disease | Anophthalmia-microphthalmia syndrome | 2.36e-04 | 21 | 32 | 2 | cv:C5680330 | |
| Disease | physical activity measurement, body mass index | 2.57e-04 | 114 | 32 | 3 | EFO_0004340, EFO_0008002 | |
| Disease | Renal glomerular disease | 2.84e-04 | 23 | 32 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.84e-04 | 23 | 32 | 2 | C4521256 | |
| Disease | anterior thigh muscle fat infiltration measurement | 4.23e-04 | 28 | 32 | 2 | EFO_0020936 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 4.23e-04 | 28 | 32 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | hyperuricemia | 5.89e-04 | 33 | 32 | 2 | EFO_0009104 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.96e-04 | 152 | 32 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Craniofacial Abnormalities | 6.42e-04 | 156 | 32 | 3 | C0376634 | |
| Disease | posterior thigh muscle fat infiltration measurement | 6.63e-04 | 35 | 32 | 2 | EFO_0020934 | |
| Disease | Breast adenocarcinoma | 9.10e-04 | 41 | 32 | 2 | C0858252 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 9.10e-04 | 41 | 32 | 2 | C0496956 | |
| Disease | Carcinoma, Transitional Cell | 9.10e-04 | 41 | 32 | 2 | C0007138 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQQPMMPVPGQHSMT | 96 | Q99217 | |
| PIQHQMPPMTPMAPM | 1951 | Q09472 | |
| MPGMVPPHVPPQMLN | 1 | Q5T035 | |
| GMAISPSRMPQPPNM | 761 | Q92793 | |
| PSRMPQPPNMMGAHT | 766 | Q92793 | |
| HMQPPPLEPPSVDMM | 2251 | Q8NFD5 | |
| PNGLELPFMMMPHPL | 426 | Q9UI36 | |
| LPFMMMPHPLIPVSL | 431 | Q9UI36 | |
| ASPPPMSPMKAMSNP | 391 | Q9P2D1 | |
| MSPMKAMSNPAGTPP | 396 | Q9P2D1 | |
| PGQPAMMQPMAHYPS | 796 | Q8WWM7 | |
| PQGMHMPPQLETPRM | 356 | Q96EV2 | |
| PGPAMAKTPPQMHPV | 446 | Q9H0B3 | |
| KIHFNPPLPMMRNQM | 271 | P27338 | |
| PMPSFTMANNLPMQP | 331 | P26367 | |
| GAPMVQPPPAAMMTQ | 256 | Q9UJ55 | |
| ITHKNQMPMLMGPPP | 711 | P23743 | |
| QMPMLMGPPPRSTNF | 716 | P23743 | |
| PPHQPLQMPKMMPEN | 196 | P41161 | |
| GMPGMVPPHVPPQML | 351 | Q9NZB2 | |
| MATMASPKQPPPNMI | 1276 | O94916 | |
| MIQMPAYQPGMVPAP | 826 | Q96JP2 | |
| KITHKNQAPMMMGPP | 761 | P49619 | |
| LMMPKPPNLIMNPSN | 2436 | P46100 | |
| TPEPMPMSMQPLKGQ | 1541 | P29400 | |
| PGPMPPQQHLMGKAM | 1271 | Q86UU0 | |
| KMMMPFDSQPPQPVI | 1236 | Q92859 | |
| QIPGPGSMMPGQHMP | 1016 | Q92922 | |
| PGMPIPLPGVAMMQI | 371 | O14776 | |
| MQSLLPAPPTQNMPM | 71 | Q15532 | |
| PSALHPSGLMKPMMP | 696 | Q5JSZ5 | |
| MNSMNPMKPALPPAP | 1 | Q8NF64 | |
| LPMLHDPPKMGMPVV | 31 | Q96KM6 | |
| MLPPKQPMYAMPGLA | 321 | Q96NM4 | |
| PAPQGMIMGHPPQEM | 796 | Q9C0J8 | |
| YRLHQGKGMMPPPPM | 461 | Q15637 | |
| VPGMPPMTQAPRIMH | 141 | P09012 |